AMPYRA along with CAP-treatment?

A forum for the discussion of antibiotics as a potential therapy for MS
Post Reply
User avatar
UWE59
Family Member
Posts: 28
Joined: Mon May 31, 2010 2:00 pm
Location: Germany
Contact:

AMPYRA along with CAP-treatment?

Post by UWE59 »

Hello,
I´m on CAP-Wheldon since 4 weeks and want to improve walking with AMPYRA (4-Amino-Pyridine)

Do you see any problems along with Doxy/Roxi ?

About FAMPRIDINE:
AMPYRA is a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA, which was previously referred to as Fampridine-SR, is an extended release tablet formulation of dalfampridine (4-aminopyridine, 4-AP), which was previously called fampridine. In laboratory studies, dalfampridine has been found to improve impulse conduction in nerve fibers in which the insulating layer, called myelin, has been damaged. AMPYRA is being developed and commercialized in the United States by Acorda Therapeutics, and by Biogen Idec in markets outside the U.S. based on a licensing agreement with Acorda. AMPYRA is manufactured globally by Elan based on a supply agreement with Acorda.
Kind regards UWE
User avatar
Tony
Getting to Know You...
Posts: 21
Joined: Sun May 20, 2007 2:00 pm

Post by Tony »

Hi Uwe,

I have been taking 4-AP for 5 years now and am also on CAP since 4 weeks. I have no problems with that and also did many other treatments when under 4-AP, it never was a problem. Don't be discouraged by this funny German doctor WW who has not a clue about many things. But start slowly with the 4-AP, only 5mg/d at the beginning.

Good luck!

Tony
User avatar
UWE59
Family Member
Posts: 28
Joined: Mon May 31, 2010 2:00 pm
Location: Germany
Contact:

Post by UWE59 »

Thanks Tony!
..Doc WW is a very special person, I know.. :wink:

I will start with 5 mg and will go up to 4x5 mg (AMPYRA is 2x10 mg)
Kind regards UWE
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Antibiotics”